Boundless Bio, Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Boundless Bio, Stock Summary

Boundless Bio, competes with Supercom, Jacobs Solutions, Playtika Holding, Sabre Corpo, and Enersys. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. Audentes Therapeutics, Inc. was founded in 2012 and is headquartered in San Francisco, California. Audentes Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people.

Boundless Bio, Key Financial Ratios

Boundless Bio, Key Balance Sheet Accounts

Boundless Bio, Key Income Statement Accounts

Boundless Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Boundless Bio,'s current stock value. Our valuation model uses many indicators to compare Boundless Bio, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Boundless Bio, competition to find correlations between indicators driving Boundless Bio,'s intrinsic value. More Info.Boundless Bio, Common is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At present, Boundless Bio,'s Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Boundless Bio, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Boundless Bio, Common Systematic Risk

Today, most investors in Boundless Bio, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Boundless Bio,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Boundless Bio, growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Boundless Bio, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Boundless Bio, Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Boundless Bio, Common based on widely used predictive technical indicators. In general, we focus on analyzing Boundless Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Boundless Bio,'s daily price indicators and compare them against related drivers.

When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.